We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
Consensus vs. actual, and revenue trend
Consensus PT $102.08 · 26 analysts
US analyst rating / recommendation change.
A material-event filing was submitted. Check the category (guidance / executives / M&A, etc.).
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
Stored first · Google News · Yahoo Finance (English)
Triglav Investments D.O.O. Decreases Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Triglav Investments D.O.O. Decreases Stock Holdings in CVS Health Corporation $CVS MarketBeat
Norges Bank Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Norges Bank Makes New Investment in CVS Health Corporation $CVS MarketBeat
Jupiter Asset Management Ltd. Reduces Holdings in CVS Health Corporation $CVS - MarketBeat
Jupiter Asset Management Ltd. Reduces Holdings in CVS Health Corporation $CVS MarketBeat
Ilmarinen Mutual Pension Insurance Co Takes $2.94 Million Position in CVS Health Corporation $CVS - MarketBeat
Ilmarinen Mutual Pension Insurance Co Takes $2.94 Million Position in CVS Health Corporation $CVS MarketBeat
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $1.82 | — | — | $100.07B | — | Scheduled |
| FY2026 Q1 | 2026. 05. 06. | Time TBD | — | $1.41 | — | — | $94.59B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $2.35 | — | — | $275.1B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $2.28 | — | — | $179.67B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 20. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 05. 15. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 05. 14. | Bernstein | — | Maintain | Outperform → Outperform | — | Bernstein: Outperform |
| 2026. 05. 12. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 05. 12. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 2,088,622 | $165.75B | 0.27% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 22,692 | $1.8B | 0.00% | — | New position |